# Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (Text with EEA relevance), Article 83: National contact points

Extent: E+W+S+N.I.

1. Each Member State shall designate one national contact point in order to facilitate the functioning of the procedures set out in Chapters II and III.
2. Each Member State shall communicate the contact point referred to in paragraph 1 to the Commission. The Commission shall publish a list of the national contact points.

---
Source: https://www.legislation.gov.uk/eur/2014/536/article/83 (the official version)
Page: https://openlegislation.uk/eu-regulation-2014-536/article-83
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.